Tanke Biosciences Return on Equity (ROE) Growth & History (TNBI)
Tanke Biosciences's return on equity was −1.33% for fiscal 2012.
View full Tanke Biosciences company overviewTanke Biosciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2012 | 2012-12-31 | −1.33% | +24.78 pp |
| 2011 | 2011-12-31 | −26.11% | −63.63 pp |
| 2010 | 2010-12-31 | 37.51% | — |
Tanke Biosciences quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2013 | 2013-09-30 | −1.93% | −7.95 pp |
| Q2 2013 | 2013-06-30 | 0.76% | −1.00 pp |
| Q1 2013 | 2013-03-31 | −4.37% | −0.06 pp |
| Q4 2012 | 2012-12-31 | −4.83% | −18.00 pp |
| Q3 2012 | 2012-09-30 | 6.02% | +15.74 pp |
| Q2 2012 | 2012-06-30 | 1.76% | +15.80 pp |
| Q1 2012 | 2012-03-31 | −4.31% | — |
| Q4 2011 | 2011-12-31 | 13.16% | — |
| Q3 2011 | 2011-09-30 | −9.72% | — |
| Q2 2011 | 2011-06-30 | −14.04% | — |
Tanke Biosciences return on equity trends
Between the periods ended 2010-12-31 and 2012-12-31, Tanke Biosciences's return on equity decreased from 37.51% to −1.33%, a change of −38.84 percentage points. The latest reported quarter, Q3 2013, shows −1.93%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tanke Biosciences source filings ↗